As of September 2024, Orchid Pharma has a market cap of $697.38M. This makes Orchid Pharma the world's 8549th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $542.80M | 56.65% |
2023 | $346.51M | 95.71% |
2022 | $177.05M | -7.81% |
2021 | $192.05M | 220.41% |
2020 | $59.94M | 2161.47% |
2019 | $2.65M | 13.54% |
2018 | $2.33M | -74.33% |
2017 | $9.09M | -30.87% |
2016 | $13.16M | -58.54% |
2015 | $31.73M | 0.38% |
2014 | $31.61M | -1.37% |
2013 | $32.05M | -34.59% |
2012 | $49.00M | -20.45% |
2011 | $61.59M | -58.32% |
2010 | $147.77M | 65.36% |
2009 | $89.36M | 100.49% |
2008 | $44.57M | -67.96% |
2007 | $139.12M | 46.02% |
2006 | $95.27M | -18.87% |
2005 | $117.43M | 22.44% |
2004 | $95.91M | 14.25% |
2003 | $83.94M | 232.75% |
2002 | $25.23M | - |